Bangkok Genomics Innovation Stock

Bangkok Genomics Innovation Public Company Limited is a Thailand-based company that operates laboratories and provides medical analysis services. The Company provides reproductive health screening services, including screening for fetal chromosomal abnormalities from maternal blood using the NIFTY brand using Next-Generation Sequencing (NGS) technology combined with other technology to screen for chromosomal abnormalities in babies such as down syndrome to reduce the risk of miscarriage from unnecessary amniocentesis. Its other screening tests include COLOTECT Colon Cancer Screening and DNALL Personal DNA Testing. Its technology services include DNA base sequencing, RNA base sequencing and metabolism and protein omics. It also contributes to the provision of various research services, both medical and other aspects. Its customers include government customers, such as medical schools, health centers, as well as private sector customers, such as clinics, hospitals and others.